Fact CheckerSign in

NCT07737860Not yet recruiting

Impact of MBS on Body Composition, Basal Metabolic Rates and Muscle Functions in Morbid Obese Patients

Impact of Bariatric Surgery on Body Composition, Basal Metabolic Rates and Muscle Functions in Morbid Obese Patients: A Prospective Observational Study

Source: ClinicalTrials.gov · Last updated 30 Jul 2026

Brief summary (registry, in English)

PRIMARY OBJECTIVE To evaluate the changes in body composition in morbid obese patients following bariatric and metabolic surgery Secondary Objectives: 1. To assess changes in BMR in obese patients following bariatric surgery 2. To evaluate muscles strength and muscle performance parameters in obese patients following bariatric surgery 3. To assess change in inflammatory and metabolic parameters following bariatric surgery In this study, morbidly obese patients undergoing bariatric surgery will be assessed at baseline and followed by 3rd and 6 months to evaluate various physiological and biochemical changes. Anthropometric measurements including height, weight, BMI, and waist-hip ratio will be recorded. Body composition will be assessed using Bioelectrical Impedance Analysis (BIA), which will provide data on percentage body fat (PBF), segmental muscle mass (SMM), segmental fat mass (SFM), and skeletal muscle index (SMI). Basal metabolic rate (BMR) will also be measured through BIA. Muscle strength will be evaluated using a hand grip dynamometer, while muscle performance will be assessed via gait speed using the 6-meter walk test. Inflammatory markers such as high-sensitivity C-reactive protein (HsCRP), erythrocyte sedimentation rate (ESR), and interleukin-6 (IL-6) will be analyzed. Additionally, metabolic parameters including thyroid-stimulating hormone (TSH), fasting and postprandial blood glucose, HbA1c, and lipid profile will be measured to understand the systemic effects of the surgery.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
21 (estimated)
First submitted
16 Feb 2026
Start date
1 Sept 2026
Primary completion date
Jun 2027
Lead sponsor
All India Institute of Medical Sciences, Bhubaneswar
Diseases
Obesity
NCT number
NCT07737860

What you commit to

  • Study type: Observational
  • Planned participants: 21
  • From 1 Sept 2026 to the primary completion date, Jun 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • History of prior bariatric surgery

Other illness

  • Known endocrine disorders (Cushing's and Untreated hypothyroidism)

Other

  • Inability to comply with follow-up scheduleLost to follow-up before 3 months post-treatment

Who the study is looking for

  • BMI \> 35 with or without obesity-related comorbidities Planned for Bariatric and Metabolic Surgery

Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.